cysteine has been researched along with Leishmaniasis, Visceral in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Ali, N; Chhajer, R; Das, P; Das, VNR; Didwania, N; Ejazi, SA; Goswami, RP; Kamran, M; Kar, R; Mazumder, S; Pandey, K; Rahaman, M; Sabur, A | 1 |
Ali, N; Bhattacharyya, A; Choudhury, ST; Costa, CHN; Costa, DL; da Silva, FO; Das, P; Das, VNR; Ejazi, SA; Goswami, RP; Kamran, M; Pandey, K; Rahaman, M; Tanishka, K | 1 |
Gupta, S; Sane, SA; Shakya, N; Shankar, S | 1 |
3 other study(ies) available for cysteine and Leishmaniasis, Visceral
Article | Year |
---|---|
Evaluation of Cysteine Protease C of Leishmania donovani in Comparison with Glycoprotein 63 and Elongation Factor 1α for Diagnosis of Human Visceral Leishmaniasis and for Posttreatment Follow-Up Response.
Topics: Antibodies, Protozoan; Antigens, Protozoan; Cysteine; Cysteine Proteases; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Glycoproteins; Humans; Leishmania donovani; Leishmaniasis, Visceral; Peptide Elongation Factor 1; Sensitivity and Specificity | 2020 |
A Novel Antigen, Otubain Cysteine Peptidase of Leishmania donovani, for the Serodiagnosis of Visceral Leishmaniasis and for Monitoring Treatment Response.
Topics: Antibodies, Protozoan; Antigens, Protozoan; Cysteine; Enzyme-Linked Immunosorbent Assay; Humans; Leishmania donovani; Leishmaniasis, Visceral; Peptide Hydrolases; Sensitivity and Specificity; Serologic Tests | 2021 |
Effect of Pam3Cys induced protection on the therapeutic efficacy of miltefosine against experimental visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Cricetinae; Cysteine; Female; Leishmaniasis, Visceral; Lipoproteins; Male; Mice; Mice, Inbred BALB C; Phosphorylcholine | 2011 |